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ABSTRACT
Background
Surgical margin status is an important predictor of risk
of relapse among patients with rectal cancer.
Methods
Patients referred to the British Columbia Cancer Agency
for consideration of adjuvant therapy for rectal adeno-
carcinoma were included. Predictors of margin positivity
were determined from uni- and multivariate analysis.
Results
Among 340 patients, 83% had negative resection mar-
gins. In 268 patients with resectable tumours, a sig-
nificantly higher rate of margin positivity was observed
in low rectal tumours (32.2%) as compared with mid-
rectal (3.9%) and high rectal (14.3%) tumours. Among
59 patients with locally advanced rectal cancer treated
with preoperative radiation (with or without chemo-
therapy), 32% with low tumours had margin positivity.
Of patients with T4 tumours, 50% (11/22) had a posi-
tive resection margin.
Conclusions
In a population cohort, distal-third rectal location, locally
advanced presentation, and T4 cancer represent subgroups
for whom further improvement in therapy is required.
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1. INTRODUCTION
Previously, outcomes for rectal cancer management
in British Columbia were reported for the year 19961.
In that retrospective review, worse outcomes were
associated with positive margins and a shorter distance
from tumour to anus. At that time, BC Cancer Agency
guidelines for rectal cancer specified that postopera-
tive chemoradiation be given for stage II and III can-
cers and that preoperative chemoradiation be given for
clinically fixed tumours. The 1996 data indicated that
the surgical technique of total mesorectal excision
(TME) was not consistently performed as the surgical
technique of rectal cancer excision.
Subsequently in British Columbia, resectable rec-
tal cancers were treated using preoperative short-course
radiation (25 Gy given in 5 daily fractions within 1 week
before surgery) with TME as the surgical technique,
based on the excellent rectal cancer management out-
comes in a Dutch trial2. In the present report, we ex-
amine radial margins for a provincial population in the
year subsequent to that change in management proto-
col, with an analysis of factors predictive of positive
surgical resection margins.
2. METHODS
The Colorectal Cancer Outcomes Unit (CRCOU) data-
base was used to identify all patients with adenocarci-
noma of the rectum referred to the BC Cancer Agency
from October 1, 2003, to September 30, 2004. The
CRCOU prospectively collects demographic, pathologic,
and treatment data for all referred patients with
colorectal cancer. Locoregional and distant recurrence
and survival are collected prospectively. According to
the provincial cancer registry database, 75% of all
patients with rectal cancer were referred to the BC
Cancer Agency during the period studied. Patients were
excluded if they had in situ disease, if they had meta-
static disease at presentation, if they did not undergo a
surgical resection, or if they underwent a local exci-
sion only.PHANG et al.
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Provincial cancer management guidelines in Brit-
ish Columbia were revised to recommend short-course
preoperative radiation for all resectable stage II and III
rectal cancers. Long-course preoperative radiation
(≥45) Gy given over 4 or more weeks) in combination
with 5-fluorouracil (5-FU) chemotherapy was reserved
for locally advanced disease (clinical fixation, or tu-
mour or lymph nodes approaching the predicted
mesorectal resection margin), or to increase chances
of a sphincter-sparing resection. Postoperative long-
course chemoradiation was recommended for stage II
and III when not given preoperatively. Bolus adjuvant
chemotherapy with 5-FU and leucovorin was recom-
mended postoperatively for all patients with stage II
and III tumours.
Patients were categorized as having resectable
cancer or locally advanced cancer, defined clinically
as limited mobility or fixed tumour, or radiologically
as primary tumour or nodes at or close to mesorectal
fascia to the extent that it was unlikely that the tumour
could be resected with clear margins. Tumours were
also classified by location in the upper (11–15 cm),
mid- (6–10 cm), or distal rectum (1–5 cm) according
to tumour distance from the anus, and by surgical pro-
cedure: anterior resection (AntR) or abdominoperineal
resection (APR).
The TME specimen grade was assigned either as
“complete,” with a grading of “good” (mesorectal fas-
cia intact) or “fair” (minor defects in mesorectal fas-
cia), or as “incomplete” (large defects in mesorectal
fascia exposing muscularis of the rectal wall)3. A nega-
tive margin was recorded if the distance from tumour
to the circumferential margin was more than 1 mm.
Univariate and multivariate analyses were used to
determine variables predictive of margin positivity and
were conducted separately in patients who had resect-
able and locally advanced rectal cancer. Univariate
analysis used the chi-square and Fisher exact tests;
patients with unknown values were excluded from the
analyses. A 10% significance level was used as the
cutoff to enter variables into the multivariate analysis.
Multivariate analysis used logistic regression and in-
cluded only patients with known values for all vari-
ables evaluated.
The study received approval from the UBC Research
Ethics Board.
3. RESULTS
Table I summarizes patient and treatment characteris-
tics for the 340 patients that met the eligibility criteria.
Pathologic cancer stage distribution (including
downstaging as a result of long-course preoperative
treatment) was 2.1% stage 0, 23% stage I, 28% stage
II, 46% stage III, and 0.9% unknown stage. Tumour lo-
cation distribution was 29% distal rectum, 54% mid-
rectum, and 18% upper rectum.
In 78% of cases, TME was the reported surgical
procedure. Quality of TME was reported in only 31%
of cases. The TME specimen grade was “complete” in
88% of cases (71% “good,” 17% “fair”) and “incom-
plete” in 12%3. Median number of nodes reported was
11, with 37% of reports including more than 12 nodes,
29% reporting 9–12 nodes, and 31% reporting fewer
than 9 nodes. Circumferential margin status was re-
ported in 98% of cases.
A negative margin was achieved in 83% of cases.
Table II shows margin positivity according to tumour
location and clinical T stage for the resectable group;
Table III provides the same information for the locally
advanced group. Patients with resectable tumours
treated with preoperative short-course radiation or no
preoperative radiation had a 12% overall rate of mar-
gin positivity as compared with a 32% overall rate of
margin positivity for locally advanced tumours that
received preoperative long-course radiation. Margin
positivity was highest for the distal-third rectal loca-
tion both in cases that were resectable (32%) and in
locally advanced cases (41%). In resectable cases,
margin positivity was the lowest for the mid-rectal lo-
cation (4%); the upper-third rectal location had a 14%
rate of margin positivity. Stage T4 tumours partly ac-
count for the higher positive margin rate for the upper-
third location. Positive margins increased with
increasing clinical T stage in resectable and in locally
advanced tumours. For resectable tumours, rates of
margin positivity were 0% for T1, 8% for T2, 11% for
T3. In locally advanced tumours, rates of margin
positivity were 22% for T3 and 50% for T4.
The surgical procedure was AntR in 63% of cases
and APR in 37%. Table IV gives margin status according
TABLE I Characteristics and treatment of 340 patients with stages I–
III rectal cancer referred to the British Columbia Cancer Agency,
2003–2004
Patients (n)    340
Age (years)
Median 67
Range (32–89)
Sex [n (%)]
Men 211 (62)
Women 129 (38)
Surgical procedure [n (%)]
Anterior resection 214 (63)
Abdominoperineal resection 126 (37)
Total mesorectal excision [n (%)]
Done 265 (78)
Not done 61 (18)
Unknown 15 (4.4)
Radiation [n (%)]
Preoperative, short course 181 (53)
Preoperative, long course 68 (20)
Postoperative 47 (14)
None 44 (13)
Chemotherapy [n (%)]
Preoperative 11 (3.2)
Postoperative 119 (35)
Pre- and postoperative 35 (10)
None 175 (51)PREDICTORS OF MARGIN STATUS FOR RECTAL CANCER
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to surgical procedure and tumour height and describes
the four treatment groups. In resectable cases with and
without preoperative short-course radiation, positive
margin rates in the distal-third rectal location were 11%
for AntR and 36% for APR. In the mid-rectal location,
rates of margin positivity for resectable cases were
5% for AntR and 0% for APR. In locally advanced cases
that received preoperative long-course radiation, over-
all rates of margin positivity were 35% for AntR and
31% for APR.
Of resectable tumours, overall rates of margin
positivity were 11% for preoperative short-course ra-
diation and 16% for no preoperative radiation, with
slightly higher rates in cases with no preoperative ra-
diation at all respective tumour locations and clinical
T stages (data not shown). A small subgroup of 9 patients
with resectable cancers who received preoperative
long-course downstaging radiation had a 10% rate of
margin positivity.
Table V presents uni- and multivariate analyses of
tumour and treatment factors associated with margin
positivity in 268 patients with resectable tumours. On
univariate analysis, distal rectal location, advanced
pathologic and clinical N stage, presence of lympho-
vascular invasion, and APR were associated with mar-
gin positivity. On multivariate analysis, only distal rectal
location and advanced pathologic T and N stage were
predictive of margin positivity.
Table VI presents univariate analyses of tumour
and treatment factors associated with margin positivity
in 59 patients with locally advanced tumours that re-
ceived preoperative long-course radiation. Advanced
clinical T stage and pathologic T and N stage and “well”
or “moderate” tumour grade were predictive of margin
positivity. Mid- and distal rectal locations had equivalent
rates of margin positivity in locally advanced tumours.
A multivariable analysis could not be carried out be-
cause of the small subgroup size.
3.1 Exclusions
The study analyses excluded 2 patients with pathologic
T0 tumours, 2 patients with pathologic TX tumours, and
1 patient with pathologic NX nodes.
3.2 Statistical Analyses
Patients with unknown values were excluded from the
univariate analysis, although patients with clinical TX,
clinical NX, and unknown lymphovascular invasion
were included, because of the large numbers of cases
in those categories. The multivariate analyses included
179 patients with known values for all 5 variables.
4. DISCUSSION
The present study reviews the effect of a revised pro-
vincial protocol on surgical resection margins and as-
sesses factors that predict positive surgical resection
margins for rectal cancer. The change in provincial
guidelines for rectal cancer management was indicated
after a review in 1996 of outcomes for rectal cancer
management that showed relatively high rates of pel-
vic recurrence, particularly for stage III cancers (27%).
In that review, pathology assessment was incomplete,
in that only 50% of cases reported radial margin sta-
tus. Here, we are pleased to find a 98% rate of radial
margin assessment. (Although we cannot compare the
rate of surgical radial margin negativity in 1996 to the
rate in patients treated after the change in the provin-
cial guidelines, we discuss the current overall 83% rate
of margin negativity in the context of other agencies
using similar management guidelines.) Higher rates
of margin positivity were found in the distal-third rec-
tal location and in locally advanced cancer.
For resectable tumours, negative margin rates were
100% for T1, 92% for T2, and 89% for T3. A “com-
plete” TME rate of 88% was reported in a subset of
cases. These data likely indicate that surgeons in Brit-
ish Columbia are performing TME as the surgical pro-
cedure for rectal cancer excision. By comparison, the
Dutch TME study reported a 76% TME “complete” rate4.
To our knowledge, ours is the first North American
TABLE II Margin positivity according to tumour distance from the anus and clinical T stage in 268 patients with resectable tumours who received
either no preoperative treatment or short-course radiation
Tumour Cases with positive resection margin [n/N (%)]
distance T1 T2 T3 T4 TX All
<5 cm 0/3 4/17 11/33 0 4/6 19/59 (32)
5–10 cm 0/5 2/49 2/78 0/3 1/18 5/153 (4)
11–15 cm 0/1 0/8 2/20 0 6/27 8/56 (14)
Total 0/9 (0) 6/74 (8) 15/131 (11) 0/4 (0) 11/51 (22) 32/268 (12)
TABLE IIIMargin positivity according to tumour distance from the
anus and clinical T stage in 59 patients with locally advanced tu-
mours who received preoperative radiation ≥45 Gy, with or without
chemotherapy
Tumour Cases with positive resection margin [n/N (%)]
distance T2 T3 T4 All
<5 cm 1/0 6/17 8/17 14/34 (41)
5–10 cm 0/1 2/16 3/5 5/22 (23)
11–15 cm 0/1 0/3 0/0 0/3 (0)
Total 0/1 (1) 8/36 (22) 11/22 (50) 19/59 (32)PHANG et al.
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report of a population-based outcome for rectal cancer
management using the TME protocol.
In patients with resectable rectal cancer, higher
margin positivity was observed in distal-third rectal
tumours (32.2%) as compared with mid- (3.9%) and
upper-third (14.3%) rectal tumours; that higher margin
positivity remained significant in the univariate and
multivariate analyses alike. Most of the positive mar-
gins in upper-third tumours related to anteriorly located
tumours that came within 1 mm of, or that perforated,
the serosa. These margin positivity rates are similar to
those reported in the Dutch TME study: 27% for distal
third, 13% for middle third, and 14% for upper third of
the rectum4.
More-advanced pathologic T and N stage were also
independent predictors of margin positivity. A higher
rate of margin positivity (32%) was also seen in locally
advanced tumours despite preoperative long-course
chemoradiation. The highest positive margin rate (50%)
occurred in T4 cancers. These data indicate that surgi-
cal techniques for clearance of the radial margin for
distal-third rectal location and locally advanced tumours
may require more attention—with wider, more radical
resection—similar to observations by others5,6.
The TME surgical technique in the distal pelvis is
difficult because the confines of the bony pelvis and
urogenital organs preclude good visualization of
dissection planes. Higher rates of margin positivity oc-
curred for both APR (35%) and AntR (31%) of resect-
able tumours in the distal-third location. These data
may indicate that a perineal approach, as in APR, does
not provide improved visualization of the dissection
planes in the distal third of the rectum. There is no
proven technique that will improve visualization and
radial margin clearance for the distal-third rectal tu-
mour location, although definitive data are pending for
laparoscopic TME and trans-sacral approaches. Fur-
thermore, preoperative assessment of clear margins
for cancers in the anterior rectal wall is limited by cur-
rent imaging modalities. As a result, a decision for en
bloc resection of anterior urogenital organs in the set-
ting of anterior rectal location must be made on clini-
cal impression.
In addition to improved surgical technique, the Dutch
group has suggested increased use of preoperative
chemoradiation in an attempt to reduce the rate of mar-
gin positivity5,6. A multicentre Polish rectal cancer trial7,8
compared short-course preoperative radiation with long-
course preoperative chemoradiation in patients with
rectal carcinoma in whom at least the inferior margin of
the tumour was palpable. In that trial, the rate of margin
positivity was significantly lower after preoperative
TABLE IVMargin status according to surgical procedure and tumour distance from the anus, by treatment group
Treatment Surgical     Tumour distance from the anus
group procedure ≤5 cm 6–10 cm 11–15 cm
R0 R+ R0 R+ R? R0 R+ R?
Resectable tumour, AntR 51 8 9 41 1 4 11
pre-op RT 25 Gy APR 26 13 26 0 0 0 0 0
in 1 week (n=181)
≤5 cm 5–10 cm 11–15 cm
R0 R+ R0 R+ R? R0 R+
Resectable tumour, AntR 10 401 10
pre-op RT ≥45 Gy, APR 10 100 00
±chemotherapya (n=9)
≤5 cm 5–10 cm 11–15 cm
R0 R+ R0 R+ R0 R+
Locally advanced tumours,b AntR 22 84 10
pre-op RT ≥45 Gy, APR 18 12 9 1 2 0
±chemotherapy (n=59)
≤5 cm 5–10 cm 11–15 cm
R0 R+ R? R0 R+ R0 R+
No pre-op treatment (n=91) AntR 3 0 0 30 1 33 7
APR 65 230 10
a Resectable tumour treated to reduce bulk before attempted anterior resection.
b Defined clinically as limited mobility or fixed tumour, or radiologically as primary tumour or nodes at or close to mesorectal fascia to the
extent that tumour resection with clear margins would be an unlikely possibility.
R0 = all margins clear; R+ = margin ≤1 mm or macroscopic residual disease; R? = margin status not specified in pathology report; RT = radiation
therapy; AntR = anterior resection; APR = abdominoperineal resection.PREDICTORS OF MARGIN STATUS FOR RECTAL CANCER
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TABLE V Uni- and multivariate analysis of tumour and treatment fac-
tors predictive of positive margin status among 268 patients with
resectable tumours treated with short-course preoperative radiation
Tumour and Patients Proportion Univariate Multivariate
treatment (n) with positive analysis analysis
factors margins p value p value
(test type) (n=179)
Tumour distance 268 <0.0001 <0.0019
from the anus (chi-square)
<5 cm 59 32.2
5–10 cm 153 3.9
11–15 cm 56 14.3
Lymphovascular 182 0.0004 0.64
invasion (chi-square)
Yes 49 26.5
No 133 6.0
Surgical procedure 268 8.0 0.0009 0.87
AntR 188 22.5 (chi-square)
APR 80 22.5
Clinical T stage 268 0.11
T1 9 0.0 (Fisher exact)
T2 74 8.1
T3 131 11.5
T4 3 0.0
TX 51 23.5
Clinical N stage 268 0.0034
N0 117 6.8 (chi-square)
N1 52 7.7
N2 12 8.3
NX 87 23.0
Pathologic T stage 264 <0.0001 <0.0001
T1 17 5.9 (chi-square)
T2 71 1.4
T3 163 12.9
T4 13 76.9
Pathologic N stage 266 <0.0001 0.02
N0 140 5.0 (chi-square)
N1 79 15.2
N2 47 29.8
Tumour grade 262 0.22
Poor 15 0.0 (Fisher exact)
Well/moderate 247 13.0
TME 255 0.78
Yes 207 12.5 (chi-square)
No 48 11.1
Sex 268
Men 166 11.5 0.58
Women 102 13.7
AntR = anterior resection; APR = abdominoperineal resection; TME =
total mesorectal excision.
TABLE VIUnivariate analysisa of tumour and treatment factors pre-
dictive of positive margin status among 59 patients who received
preoperative radiation with or without chemotherapy
Tumour and Patients Proportion p Value
treatment (n) with positive (test type)
factors margins
Tumour distance 59 0.0999
from the anus (chi-square)
<5 cm 34 32.2
≥5 cm 25 20.0
Lymphovascular 41 0.3061
invasion (chi-square)
Yes 15 46.7
No 26 26.9
Surgical procedure 59 0.7659
AntR 17 35.3 (chi-square)
APR 42 31.0
Clinical T stage 59 0.0423
T1 0 (Fisher exact)
T2/T3 37 21.6
T4 22 50.0
TX 0
Clinical N stage 59 0.4610
N0 19 31.6 (chi-square)
N1 24 33.3
N2 11 18.2
NX 5 60.0
Pathologic T stage 56 0.0011
T1 0 (Fisher exact)
T2 12 0.0
T3 34 35.3
T4 10 70.0
Pathologic N stage 59 0.0159
N0 34 17.7 (chi-square)
N1 18 50.0
N2 7 57.1
Tumour grade 52 0.0395
Poor 8 0.0 (Fisher exact)
Well/moderate 44 40.9
TME 57 0.4893
Yes 45 28.9 (chi-square)
No 12 41.7
a Patients with unknown values were excluded from the
univariate analysis.
AntR = anterior resection; APR = abdominoperineal resection; TME =
total mesorectal excision.
chemoradiation than after short-course treatment (4%
compared with 13%)7, but the 4-year actuarial local
recurrence rates were not significantly different (10.6%
after short-course treatment and 14.2% after chemo-
radiation)8. The authors rightly point out that surgery
follows too soon after short-course treatment to allow
for any significant tumour regression; they suggest that
if a greater interval is left between radiation and sur-
gery, the rate of margin positivity should fall. That hy-
pothesis is addressed by the ongoing Stockholm III trial.
On the other hand, the overall number of patients with
lower-third rectal tumours in the Polish trial was rela-
tively small—a total of 312 patients were analyzed, and
the mean inferior distance of the tumour from the anal
verge was 5.8 cm7. The number of patients in the sub-
group may therefore have been too small to detect a
difference in local recurrence.
Currently, potentially more-effective preoperative
downstaging therapies, including agents such as oxaliplatin
and bevacizumab in addition to conventional 5-FU and ra-
diation, are being evaluated in phase II and III clinical tri-
als. Patients with distal-third and locally advanced rectalPHANG et al.
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cancers should be referred to those clinical trials. Mean-
while, provincial practice guidelines in British Columbia
were amended in 2006 to recommend that all patients with
stage II or III distal-third rectal cancers be offered
preoperative chemoradiation to achieve downstaging.
In the present study, a standard definition of margin
positivity was used and defined as tumour within 1 mm
or less from the margin. Not all tumours with a close
pathologic margin will relapse, but involved margin
status has been shown to be associated with an in-
creased risk of both local and distant recurrence, and
approximately 30%–40% of patients with positive mar-
gins will experience a local or distant event1,9,10.
Preoperative radiation (as compared with postopera-
tive radiation) has been associated with improved rates
of local recurrence11,12. Locoregional and distant re-
currence will be reported for that cohort once adequate
follow-up has been reached.
5. CONCLUSIONS
Provincial guidelines for rectal cancer management that
include preoperative radiation and TME as the surgical
technique for rectal cancer excision have resulted in
surgical outcomes similar to those achieved by others
using that protocol. Distal-third rectal location and lo-
cally advanced cancers had high rates of margin
positivity. Provincial practice guidelines have been
amended to specify that all patients with stage II and
III distal-third rectal cancer be treated with preoperative
downstaging chemoradiation. To improve surgical out-
comes, improved locoregional therapy is urgently re-
quired for patients with distal-third rectal cancer.
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